[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vaxart Inc 310 Utah Avenue Suite 150 South San Francisco CA 94080 USA

www.vaxart.com Employees: 65 P: 650-550-3500

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus, as well as a therapeutic vaccine for human papillomavirus. Vaxart, Inc., formerly known as Aviragen Therapeutics, is based in South San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 157,356
Enterprise Value, $K 103,546
Shares Outstanding, K 241,974
Float, K 235,199
% Float 97.20%
Short Interest, K 3,044
Short Float 1.26%
Days to Cover 5.00
Short Volume Ratio 0.38
% of Insider Shareholders 2.80%
% of Institutional Shareholders 18.05%

Financials:

Annual Sales, $ 237,260 K
Annual Net Income, $ 16,330 K
Last Quarter Sales, $ 39,230 K
Last Quarter Net Income, $ 5,180 K
EBIT, $ 38,180 K
EBITDA, $ 46,480 K

Growth:

1-Year Return 56.96%
3-Year Return -51.47%
5-Year Return -90.29%
5-Year Revenue Growth 5,758.27%
5-Year Earnings Growth 119.44%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.02 on 05/07/26
Next Earnings Date 08/12/26
Earnings Per Share ttm 0.15
EPS Growth vs. Prev Qtr -91.67%
EPS Growth vs. Prev Year 128.57%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-11 on 02/14/18

VXRT Ratios

Ratio
Price/Earnings ttm 4.60
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 61.43%
Return-on-Assets % 20.07%
Profit Margin % 6.88%
Debt/Equity 0.00
Price/Sales 0.70
Price/Cash Flow 6.74
Price/Book 1.77
Book Value/Share 0.39
Interest Coverage 6.96
60-Month Beta 1.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.